Halla Sif Ólafsdóttir

Publikationer
Populärvetenskap och samverkan

Artiklar

Journal article: RADIOTHERAPY AND ONCOLOGY. 2023;182:s1894-s1895
PO-2110 Normalised odds ratios help understand the relative importance of dose in multivariable models
Dalqvist E; Rancati T; Ólafsdóttir H; Gagliardi G; von Döbeln GA; Nilsson M; Klevebro F; Onjukka E
Article: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2023;40:100610
Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study
Olafsdottir HS; Dalqvist E; Onjukka E; Klevebro F; Nilsson M; Gagliardi G; von Dobeln GA
Journal article: DISEASES OF THE ESOPHAGUS. 2022;35(Supplement_2):doac051.397
397. NEOADJUVANT CHEMORADIOTHERAPY VERSUS NEOADJUVANT CHEMOTHERAPY AND POSTOPERATIVE COMPLICATIONS AFTER ESOPHAGECTOMY FOR CANCER
Olafsdottir H; Dalqvist E; Hamida O; Onjukka E; Klevebro F; Nilsson M; Gagliardi G; von Döbeln GA
Article: FRONTIERS IN ONCOLOGY. 2022;12:917961
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
Nilsson M; Olafsdottir H; Alexandersson von Doebeln G; Villegas F; Gagliardi G; Hellstroem M; Wang Q-L; Johansson H; Gebski V; Hedberg J; Klevebro F; Markar S; Smyth E; Lagergren P; Al-Haidari G; Rekstad LC; Aahlin EK; Wallner B; Edholm D; Johansson J; Szabo E; Reynolds JV; Pramesh CS; Mummudi N; Joshi A; Ferri L; Wong RKS; O'Callaghan C; Lukovic J; Chan KKW; Leong T; Barbour A; Smithers M; Li Y; Kang X; Kong F-M; Chao Y-K; Crosby T; Bruns C; van Laarhoven H; van Berge Henegouwen M; van Hillegersberg R; Rosati R; Piessen G; de Manzoni G; Lordick F
Article: RADIATION ONCOLOGY. 2021;16(1):153
Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study
Olafsdottir HS; Klevebro F; Ndegwa N; Alexandersson von Dobeln G
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2020;76(7):1029-1041
Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy-a retrospective analysis of a register-based patient cohort
Ekheden I; Ebrahim F; olafsdottir H; Raaschou P; Wettermark B; Henriksson R; Ye W
Article: ICELANDIC MEDICAL JOURNAL. 2016;102(3):125-130
[Epidemiology of the two types of gastric adenocarcinoma in Iceland according to the Laurén histological classification 1990-2009].
Olafsdottir HS; Alexiusdottir KK; Lund SH; Jonasson JG; Jonsson T; Skuladottir H
Article: NATURE GENETICS. 2015;47(8):906-910
Loss-of-function variants in ATM confer risk of gastric cancer.
Helgason H; Rafnar T; Olafsdottir HS; Jonasson JG; Sigurdsson A; Stacey SN; Jonasdottir A; Tryggvadottir L; Alexiusdottir K; Haraldsson A; le Roux L; Gudmundsson J; Johannsdottir H; Oddsson A; Gylfason A; Magnusson OT; Masson G; Jonsson T; Skuladottir H; Gudbjartsson DF; Thorsteinsdottir U; Sulem P; Stefansson K
Article: ICELANDIC MEDICAL JOURNAL. 2012;98(2):91-95
[Kawasaki disease in Iceland 1996-2005, epidemiology and complications].
Olafsdottir HS; Oskarsson G; Haraldsson Á

Artiklar

Nyheter från KI

Kalenderhändelser från KI